Back to HALO
Verity Asset Management, Inc. → HALO
Verity Asset Management, Inc. HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$5.4M
Q3 2026
Peak value
$5.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $3.5M |
| Q4 2025 | $3.6M |
| Q1 2026 | $3.4M |
| Q2 2026 | $4.3M |
| Q3 2026 | $5.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $5.4M | 49.3K | — | — |
| Q2 2026 | $4.3M | 55.5K | — | — |
| Q1 2026 | $3.4M | 53.1K | — | — |
| Q4 2025 | $3.6M | 53.1K | — | — |
| Q3 2025 | $3.5M | 47.6K | — | — |
Other funds holding HALO
$545.3M
$405.4M
$405.4M
$319.1M
$251.9M
$236.6M
$176.7M
$148.6M
Other Verity Asset Management, Inc. positions
SPY
$20MSPDR SP 500 ETF TR TR UNIT
SPY
$15.7MSPDR SP 500 ETF TR TR UNIT
SPY
$13.4MSTATE STREET SPDR SP 500 ETF TRUST
SPY
$13.1MSTATE STREET SPDR SP 500 ETF TRUST
SPY
$9.9MSTATE STREET SPDR SP 500 ETF TRUST
J
$7.7MINVESCO BULLETSHARES 2026 HIGH YIELD CORPORATE BOND ETF
ETHA
$7.6MISHARES CORE SP 500 ETF
J
$7.4MINVESCO BULLETSHARES 2026 HIGH YIELD CORPORATE BOND ETF